Cancer Research Horizons
London, Englandcancerresearchuk.org
Overview
Cancer Research Horizons is the innovation arm of Cancer Research UK, the world's largest charitable funder of cancer research. It acts as a venture philanthropy fund focused on bridging the gap between academic research and commercialization by investing in early-stage oncology opportunities. It supports the creation of spin-out companies, provides seed funding, and facilitates partnerships to develop new cancer treatments, diagnostics, and medical devices. All financial returns are reinvested into the fund and into further cancer research.
Portfolio Companies
6
Website
cancerresearchuk.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Infinitopes Precision Immunomics | Jan 2026 | Seed | Co-investor |
| Laigo Bio | Dec 2025 | Seed | Co-investor |
| 52North | Dec 2024 | Series A | Co-investor |
| Myricx Bio | Jul 2024 | Series A | Co-investor |
| Mercy BioAnalytics | Apr 2023 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.